These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Architecture of basic building blocks in protein and domain structural interaction networks. Moon HS; Bhak J; Lee KH; Lee D Bioinformatics; 2005 Apr; 21(8):1479-86. PubMed ID: 15613386 [TBL] [Abstract][Full Text] [Related]
24. Affinity capillary electrophoresis analyses of protein-protein interactions in target-directed drug discovery. Pierceall WE; Zhang L; Hughes DE Methods Mol Biol; 2004; 261():187-98. PubMed ID: 15064459 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional modeling of protein interactions and complexes is going 'omics. Stein A; Mosca R; Aloy P Curr Opin Struct Biol; 2011 Apr; 21(2):200-8. PubMed ID: 21320770 [TBL] [Abstract][Full Text] [Related]
27. From protein interaction networks to novel therapeutic strategies. Jaeger S; Aloy P IUBMB Life; 2012 Jun; 64(6):529-37. PubMed ID: 22573601 [TBL] [Abstract][Full Text] [Related]
28. Network analysis has diverse roles in drug discovery. Hasan S; Bonde BK; Buchan NS; Hall MD Drug Discov Today; 2012 Aug; 17(15-16):869-74. PubMed ID: 22627007 [TBL] [Abstract][Full Text] [Related]
29. Recognition of proline-rich motifs by protein-protein-interaction domains. Ball LJ; Kühne R; Schneider-Mergener J; Oschkinat H Angew Chem Int Ed Engl; 2005 May; 44(19):2852-69. PubMed ID: 15880548 [TBL] [Abstract][Full Text] [Related]
30. Interactions via intrinsically disordered regions: what kind of motifs? Pancsa R; Fuxreiter M IUBMB Life; 2012 Jun; 64(6):513-20. PubMed ID: 22535488 [TBL] [Abstract][Full Text] [Related]
31. Identification and mapping of protein-protein interactions by a combination of cross-linking, cleavage, and proteomics. Trakselis MA; Alley SC; Ishmael FT Bioconjug Chem; 2005; 16(4):741-50. PubMed ID: 16029014 [TBL] [Abstract][Full Text] [Related]
32. Predicting drug targets based on protein domains. Wang YY; Nacher JC; Zhao XM Mol Biosyst; 2012 Apr; 8(5):1528-34. PubMed ID: 22402667 [TBL] [Abstract][Full Text] [Related]
33. Transient protein-protein interactions. Acuner Ozbabacan SE; Engin HB; Gursoy A; Keskin O Protein Eng Des Sel; 2011 Sep; 24(9):635-48. PubMed ID: 21676899 [TBL] [Abstract][Full Text] [Related]
34. The molecular architecture of protein-protein binding sites. Reichmann D; Rahat O; Cohen M; Neuvirth H; Schreiber G Curr Opin Struct Biol; 2007 Feb; 17(1):67-76. PubMed ID: 17239579 [TBL] [Abstract][Full Text] [Related]
35. Analyzing of Molecular Networks for Human Diseases and Drug Discovery. Hao T; Wang Q; Zhao L; Wu D; Wang E; Sun J Curr Top Med Chem; 2018; 18(12):1007-1014. PubMed ID: 30101711 [TBL] [Abstract][Full Text] [Related]
36. A systems biology perspective on protein structural dynamics and signal transduction. Rousseau F; Schymkowitz J Curr Opin Struct Biol; 2005 Feb; 15(1):23-30. PubMed ID: 15718129 [TBL] [Abstract][Full Text] [Related]
37. Structure, dynamics, assembly, and evolution of protein complexes. Marsh JA; Teichmann SA Annu Rev Biochem; 2015; 84():551-75. PubMed ID: 25494300 [TBL] [Abstract][Full Text] [Related]
38. Drug-target interaction prediction by random walk on the heterogeneous network. Chen X; Liu MX; Yan GY Mol Biosyst; 2012 Jul; 8(7):1970-8. PubMed ID: 22538619 [TBL] [Abstract][Full Text] [Related]
39. Docking interactions in protein kinase and phosphatase networks. Reményi A; Good MC; Lim WA Curr Opin Struct Biol; 2006 Dec; 16(6):676-85. PubMed ID: 17079133 [TBL] [Abstract][Full Text] [Related]
40. Human protein-protein interaction networks and the value for drug discovery. Ruffner H; Bauer A; Bouwmeester T Drug Discov Today; 2007 Sep; 12(17-18):709-16. PubMed ID: 17826683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]